Publication | Open Access
(364) A Phase I study of the intrathecal administration of resiniferatoxin for treating severe refractory pain associated with advanced cancer
28
Citations
0
References
2014
Year
Pain TherapyAdvanced CancerOncologyHealth SciencesPain MedicineIntrathecal AdministrationPharmacologyCancer PainPain ManagementSevere Refractory PainMedicinePain Research
No additional data available for this publication yet. Check back later!